title: Phospholipid mass is increased in fibroblasts bearing the Swedish amyloid precursor mutation.
abstract: Phospholipid changes occur in brain regions affected by Alzheimer disease (AD), including a marked reduction in plasmalogens, which could diminish brain function either by directly altering signaling events or by bulk membrane effects. However, model systems for studying the dynamics of lipid biosynthesis in AD are lacking. To determine if fibroblasts bearing the Swedish amyloid precursor protein (swAPP) mutation are a useful model to study the mechanism(s) associated with altered phospholipid biosynthesis in AD, we examined the steady-state phospholipid mass and composition of fibroblasts, including plasmalogens. We found a 15% increase in total phospholipid mass, accounted for by a 24% increase in the combined total of phosphatidylethanolamine and plasmanylethanolamine mass and a 19% increase in the combined total of phosphatidylcholine (PtdCho) and plasmanycholine (PakCho) mass in the swAPP mutant bearing fibroblasts. Cholesterol mass was unchanged in these cells. The changes in phospholipid mass did not alter the cellular molar composition of the phospholipids nor the cholesterol to phospholipid ratio. While plasmalogen mass was not altered, the ratio of choline plasmalogen (PlsCho) mass to PtdCho+PakCho mass was decreased 16% and there was a 14% reduction in the proportion of PlsCho as a percent of total phospholipids in the swAPP mutant bearing fibroblasts. This change in choline plasmalogen is consistent with the reported decreases in plasmalogen proportions in affected regions of AD brain, suggesting that these cells may serve as a useful model to determine the mechanism underlying changes in plasmalogen biosynthesis in AD brain.
authors.affiliation: Department of Pharmacology, Physiology, and Therapeutics and Department of Chemistry, School of Medicine and Health Sciences, University of North Dakota, 501 N. Columbia Road, Room 3700, Grand Forks, ND 58202-9037, USA. emurphy@medicine.nodak.edu
authors.forename: Eric J
authors.initials: EJ
authors.lastname: Murphy
authors.forename: Hsueh-Meei
authors.initials: HM
authors.lastname: Huang
authors.forename: Richard F
authors.initials: RF
authors.lastname: Cowburn
authors.forename: Lars
authors.initials: L
authors.lastname: Lannfelt
authors.forename: Gary E
authors.initials: GE
authors.lastname: Gibson
mesh_terms: D000544:Alzheimer Disease / Q000378:metabolism / Q000503:physiopathology; D016564:Amyloid beta-Protein Precursor / Q000235:genetics*; D002478:Cells, Cultured; D002851:Chromatography, High Pressure Liquid; D005347:Fibroblasts / Q000737:chemistry* / Q000502:physiology*; D006801:Humans; D009154:Mutation; D010743:Phospholipids / Q000032:analysis*; D010955:Plasmalogens / Q000032:analysis
chemical_list: D016564:Amyloid beta-Protein Precursor; D010743:Phospholipids; D010955:Plasmalogens